DECHRA PHARMACEUTICALS PLC

Company number 03369634

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
17 Sep 2018 SH01 Statement of capital following an allotment of shares on 12 September 2018
  • GBP 1,023,316.35
02 Jul 2018 SH01 Statement of capital following an allotment of shares on 5 June 2018
  • GBP 1,023,296.35
18 May 2018 CS01 Confirmation statement made on 13 May 2018 with no updates
  • ANNOTATION Clarification a second filed CS01 (trading status of shares and exemption from keeping a register of people with significant control (psc)) was registered on 28/01/2019
17 May 2018 SH01 Statement of capital following an allotment of shares on 24 April 2018
  • GBP 1,023,266.35
14 Mar 2018 SH01 Statement of capital following an allotment of shares on 5 March 2018
  • GBP 1,023,036.56
06 Mar 2018 RP04SH01 Second filing of a statement of capital following an allotment of shares on 14 February 2018
  • GBP 1,022,879.52
19 Feb 2018 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Share purchase agreement 12/02/2018
  • RES10 ‐ Resolution of allotment of securities
14 Feb 2018 SH01 Statement of capital following an allotment of shares on 13 February 2018
  • GBP 1,022,879.52
  • ANNOTATION Clarification a second filed SH01 was registered on 06/03/2018.
07 Feb 2018 SH01 Statement of capital following an allotment of shares on 6 February 2018
  • GBP 986,173.27
05 Jan 2018 SH01 Statement of capital following an allotment of shares on 14 December 2017
  • GBP 934,861.03
27 Oct 2017 AA Group of companies' accounts made up to 30 June 2017
26 Oct 2017 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ That pursuant to section 701 of the 701 of the 2006 act, the company is unconditionally authorised to make market purchases (within the meaning of 2006 act) of ordinary shares in the capital of the company (shares), provided that: the maximum number of shares which may be purchased is 9,318,140; (representing 100f the company's issued ordinary share capital; the minimum price is £0.01; 20/10/2017
  • RES10 ‐ Resolution of allotment of securities
15 Sep 2017 SH01 Statement of capital following an allotment of shares on 14 September 2017
  • GBP 931,961.05
10 Jul 2017 SH01 Statement of capital following an allotment of shares on 26 June 2017
  • GBP 931,787.56
03 Jul 2017 AP03 Appointment of Ms Melanie Jane Hall as a secretary on 1 July 2017
03 Jul 2017 TM02 Termination of appointment of Suzana Cross as a secretary on 1 July 2017
24 May 2017 CS01 Confirmation statement made on 13 May 2017 with no updates
23 May 2017 SH01 Statement of capital following an allotment of shares on 8 May 2017
  • GBP 931,677.86
15 Mar 2017 SH01 Statement of capital following an allotment of shares on 14 March 2017
  • GBP 930,963.96
12 Jan 2017 SH01 Statement of capital following an allotment of shares on 14 December 2016
  • GBP 930,521.9
04 Jan 2017 TM01 Termination of appointment of Michael Redmond as a director on 21 October 2016
03 Jan 2017 AP01 Appointment of Mr Richard John Cotton as a director on 3 January 2017
13 Dec 2016 AP01 Appointment of Dr Lawson Macartney as a director on 1 December 2016
22 Nov 2016 AA Group of companies' accounts made up to 30 June 2016
11 Nov 2016 RESOLUTIONS Resolutions
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities